ATYR Atyr Pharma, Inc.

Fundamentals / CIK 0001339970 / USD

Atyr Pharma, Inc. reported $190K in revenue and a net loss of $53.32M for the fiscal year ended December 31, 2025 (down 19.1% year over year), with a -29423.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATYR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$18.13M$9.07M$0-$70.19MFY 2016 Net Income: -$57.85M2016FY 2017 Net Income: -$48.21M2017FY 2018 Net Income: -$34.52M2018FY 2019 Revenue: $422KFY 2019 Net Income: -$16.22M2019FY 2020 Revenue: $10.46MFY 2020 Net Income: -$16.22M2020FY 2021 Revenue: $0FY 2021 Net Income: -$33.77M2021FY 2022 Revenue: $10.39MFY 2022 Net Income: -$45.34M2022FY 2023 Revenue: $353KFY 2023 Net Income: -$50.39M2023FY 2024 Revenue: $235KFY 2024 Net Income: -$64.02M2024FY 2025 Revenue: $190KFY 2025 Net Income: -$74.12M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $190K $235K $353K $10.39M $0 $10.46M $422K -- -- --
Research & Development $60.22M $54.37M $42.29M $42.81M $23.26M $17.29M $14.05M $20.39M $30.07M $42.85M
Total Operating Expenses $77.82M $68.15M $55.27M $56.79M $34.02M $26.37M $23.40M $32.82M $47.15M $57.94M
Operating Income -$77.63M -$67.91M -$54.92M -$46.40M -$34.02M -$15.91M -$22.98M -$32.82M -$47.15M -$57.94M
EBITDA -$76.96M -$67.21M -$54.33M -$46.17M -$33.54M -$15.34M -$22.34M -$32.07M -$46.43M -$57.04M
Income Before Tax -$74.12M -$64.02M -$50.40M -$45.34M -$33.77M -$16.23M -$23.76M -$34.52M -$48.21M -$57.90M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 -- -$49K
Net Income -$74.12M -$64.02M -$50.39M -$45.34M -$33.77M -$16.22M -$16.22M -$34.52M -$48.21M -$57.85M
Basic EPS -$32.00 -$34.40 -$37.60 -$64.00 -$70.80 -$70.80 -$281.20 -$644.40 -$1,045.20 -$97.60
Diluted EPS -$32.00 -$34.40 -$37.60 -$64.00 -$70.80 -$70.80 -$281.20 -$644.40 -$1,045.20 -$97.60
Basic Shares Outstanding 2.3M 1.9M 1.3M 710.5K 477.0K 229.0K 83.9K 53.5K 46.1K 592.0K
Diluted Shares Outstanding 2.3M 1.9M 1.3M 710.5K 477.0K 229.0K 83.9K 53.5K 46.1K 592.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 -- -- $0 $190K $0 $0 $0
Research & Development $10.45M $6.75M $7.32M $10.89M $22.13M $15.38M $11.81M $12.23M
Total Operating Expenses $18.79M $10.88M $11.44M $14.80M $26.93M $20.31M $15.77M $15.82M
Operating Income -$18.79M -$10.88M -$11.44M -$14.80M -$26.75M -$20.31M -$15.77M -$15.82M
EBITDA -$18.62M -$10.71M -$11.27M -$14.63M -$26.58M -$20.15M -$15.61M -$15.64M
Net Income -$18.26M -$10.31M -$10.79M -$13.96M -$25.74M -$19.53M -$14.88M -$14.97M
Basic EPS -$7.43 -$4.40 -$4.40 -- -$10.60 -$8.80 -$6.80 --
Diluted EPS -$7.43 -$4.40 -$4.40 -- -$10.60 -$8.80 -$6.80 --
Basic Shares Outstanding 2.5M 2.5M 2.5M -- 2.4M 2.3M 2.2M --
Diluted Shares Outstanding 2.5M 2.5M 2.5M -- 2.4M 2.3M 2.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $10.74M $11.05M $22.54M $9.98M $2.34M $16.95M $9.21M $22.96M $21.09M $38.39M
Short-Term Investments $67.94M $61.07M $75.62M $56.16M $105.6M $14.74M $21.93M $26.58M $64.03M $33.76M
Cash & Short-Term Investments $78.69M $72.12M $98.17M $66.15M $107.9M $31.69M $31.14M $49.55M $85.12M $72.15M
Total Current Assets $80.24M $81.95M $103.0M $80.87M $113.6M $35.53M $31.93M $50.80M $86.98M $74.77M
Property, Plant & Equipment, Net $4.26M $4.85M $5.53M $3.06M $543K $899K $1.27M $1.85M $2.28M $1.42M
Long-Term Investments -- -- -- -- -- -- -- -- -- $4.00M
Other Non-Current Assets $148K $66K $131K $193K $158K $213K $172K $90K $90K $333K
Total Non-Current Assets $12.77M $14.88M $17.66M $14.91M $1.97M $3.19M $4.26M $1.94M $2.37M $5.76M
Total Assets $93.00M $96.83M $120.7M $95.79M $115.5M $38.73M $36.19M $52.75M $89.36M $80.52M
Accounts Payable $3.89M $4.32M $3.53M $3.11M $1.03M $1.43M $847K $1.04M $2.28M $2.61M
Short-Term Debt -- -- -- -- -- -- $8.74M $7.77M $5.01M $339K
Deferred Revenue (Current) -- -- -- -- -- -- $208K -- -- --
Total Current Liabilities $15.15M $14.97M $16.42M $13.86M $6.01M $5.86M $12.92M $10.83M $10.39M $8.53M
Long-Term Debt -- -- -- -- -- -- -- $8.26M $14.72M $9.20M
Total Non-Current Liabilities $10.57M $12.03M $13.77M $10.64M $398K $1.38M $2.24M $8.26M $14.72M $9.20M
Total Liabilities $25.71M $27.00M $30.18M $24.50M $6.41M $7.24M $15.16M $19.10M $25.11M $17.72M
Total Debt (incl. Leases) $12.03M $13.28M $15.39M $14.29M $1.38M $2.24M $11.73M $16.03M $19.73M $9.54M
Common Stock $98K $84K $63K $29K $28K $11K $4.0K $2.0K $30K $24K
Retained Earnings -$606.2M -$532.0M -$468.0M -$417.6M -$372.3M -$338.5M -$322.3M -$298.7M -$264.2M -$216.0M
Accumulated Other Comp. Income -$8.0K -$40K -$74K -$433K -$263K -$43K -$40K -$60K -$120K -$76K
Total Stockholders' Equity $67.48M $70.02M $90.66M $71.46M $109.3M $31.65M $21.19M $33.65M $64.25M $62.80M
Total Equity $67.29M $69.83M $90.47M $71.28M $109.1M $31.48M $21.03M $33.65M $64.25M $62.80M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $13.14M $16.16M $10.01M $10.74M $6.15M $17.22M $10.36M $11.05M
Short-Term Investments $35.61M $41.26M $56.51M $67.94M $79.00M $63.13M $65.99M $61.07M
Cash & Short-Term Investments $48.75M $57.42M $66.51M $78.69M $85.15M $80.35M $76.35M $72.12M
Total Current Assets $50.16M $58.36M $67.58M $80.24M $93.01M $87.49M $83.27M $81.95M
Property, Plant & Equipment, Net $3.38M $4.13M $4.24M $4.26M $4.43M $4.53M $4.68M $4.85M
Long-Term Investments -- -- -- -- $5.10M -- -- --
Other Non-Current Assets $238K $190K $148K $148K $149K $66K $66K $66K
Total Non-Current Assets $9.65M $11.46M $12.08M $12.77M $13.64M $14.04M $13.97M $14.88M
Total Assets $59.81M $69.83M $79.65M $93.00M $106.7M $101.5M $97.25M $96.83M
Accounts Payable $3.90M $3.24M $2.75M $3.89M $4.06M $3.88M $1.53M $4.32M
Total Current Liabilities $16.46M $11.40M $11.70M $15.15M $15.68M $15.53M $10.68M $14.97M
Total Non-Current Liabilities $9.55M $9.84M $10.21M $10.57M $10.93M $11.35M $11.70M $12.03M
Total Liabilities $26.01M $21.23M $21.91M $25.71M $26.61M $26.88M $22.38M $27.00M
Total Debt (incl. Leases) $10.92M $11.30M $11.70M $12.03M $12.36M $12.68M $12.99M $13.28M
Common Stock $100K $98K $98K $98K $98K $93K $89K $84K
Retained Earnings -$645.5M -$627.3M -$617.0M -$606.2M -$592.2M -$566.5M -$546.9M -$532.0M
Accumulated Other Comp. Income -$92K -$68K -$70K -$8.0K -$1.0K -$75K -$66K -$40K
Total Stockholders' Equity $33.98M $48.79M $57.93M $67.48M $80.23M $74.84M $75.05M $70.02M
Total Equity $33.79M $48.59M $57.74M $67.29M $80.04M $74.66M $74.86M $69.83M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$74.12M -$64.02M -$50.40M -$45.34M -$33.78M -$16.23M -$23.76M -$34.52M -$48.21M -$57.85M
Depreciation & Amortization $664K $708K $592K $232K $475K $569K $635K $746K $713K $900K
Stock-Based Compensation $5.00M $2.99M $2.60M $2.15M $1.61M $1.47M $1.78M $3.43M $6.78M $5.03M
Operating Cash Flow -$61.99M -$69.12M -$33.22M -$41.89M -$33.08M -$15.30M -$20.01M -$31.06M -$42.36M -$52.86M
Capital Expenditure -$77K -$65K -$4.21M -$1.64M -$192K -$202K -$79K -$594K -$1.31M -$600K
Free Cash Flow -$62.06M -$69.18M -$37.44M -$43.53M -$33.27M -$15.50M -$20.09M -$31.66M -$43.68M -$53.46M
Purchases of Investments -$93.44M -$69.10M -$107.0M -$42.12M -$126.5M -$21.07M -$40.65M -$40.30M -$77.67M -$28.09M
Investing Cash Flow -$5.05M $17.23M -$20.13M $47.24M -$91.57M $6.90M $4.92M $37.17M -$27.64M $33.53M
Common Stock Issued -- -- -- -- -- -- -- $14K $186K $20K
Financing Cash Flow $66.01M $39.86M $66.23M $5.45M $110.0M $16.14M $1.34M -$4.24M $52.70M $4.70M
Net Change in Cash -$1.03M -$12.02M $12.88M $10.81M -$14.62M $7.74M -$13.75M $1.87M -$17.30M -$14.64M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$18.26M -$10.31M -$10.79M -$13.96M -$25.75M -$19.53M -$14.88M -$14.97M
Depreciation & Amortization $171K $168K $162K $166K $165K $166K $167K $175K
Stock-Based Compensation $2.59M $1.15M $1.31M $1.21M $1.31M $1.30M $1.18M $770K
Operating Cash Flow -$9.51M -$9.35M -$12.52M -$12.20M -$20.48M -$13.89M -$15.42M -$13.13M
Capital Expenditure -$45K -$73K -$138K -$31K -$37K -$9.0K $0 -$25K
Free Cash Flow -$9.56M -$9.42M -$12.65M -$12.23M -$20.51M -$13.90M -$15.42M -$13.16M
Purchases of Investments -$14.73M -$7.98M -$5.87M -$12.85M -$39.34M -$18.16M -$23.11M -$26.07M
Investing Cash Flow $5.72M $15.32M $11.49M $16.44M -$20.38M $3.30M -$4.42M -$6.08M
Financing Cash Flow $773K -$129K -$142K -$131K $29.62M $17.90M $18.63M $18.84M
Net Change in Cash -$3.01M $5.84M -$1.17M $4.12M -$11.24M $7.30M -$1.21M -$378K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -40856.3% -28899.6% -15557.8% -446.8% -- -152.2% -5445.0% -- -- --
Net Profit Margin -39009.5% -27243.8% -14274.5% -436.5% -- -155.2% -3844.5% -- -- --
Return on Equity (ROE) -109.8% -91.4% -55.6% -63.4% -30.9% -51.3% -76.6% -102.6% -75.0% -92.1%
Return on Assets (ROA) -79.7% -66.1% -41.8% -47.3% -29.2% -41.9% -44.8% -65.4% -53.9% -71.8%
Current Ratio 5.30x 5.48x 6.27x 5.83x 18.89x 6.06x 2.47x 4.69x 8.37x 8.77x
Quick Ratio 5.19x 4.82x 5.98x 4.77x 17.95x 5.40x 2.41x 4.57x 8.19x 8.46x
Debt to Equity 0.18x 0.19x 0.17x 0.20x 0.01x 0.07x 0.55x 0.48x 0.31x 0.15x
Revenue Growth (YoY) -19.1% -33.4% -96.6% -- -100.0% +2377.5% -- -- -- --
5Y Revenue / Share Growth -99.8% -97.5% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -40856.3% -41395.3% -- -- -28899.6%
Net Profit Margin -- -- -- -39009.5% -39537.9% -- -- -27243.8%
Return on Equity (ROE) -156.9% -124.6% -120.9% -109.8% -93.6% -89.0% -84.5% -91.4%
Return on Assets (ROA) -89.2% -87.1% -87.9% -79.7% -70.4% -65.6% -65.2% -66.1%
Current Ratio 3.05x 5.12x 5.78x 5.30x 5.93x 5.63x 7.79x 5.48x
Quick Ratio 2.96x 5.04x 5.69x 5.19x 5.43x 5.17x 7.15x 4.82x
Debt to Equity 0.32x 0.23x 0.20x 0.18x 0.15x 0.17x 0.17x 0.19x
Revenue Growth (YoY) -100.0% -- -- -- -- -- -100.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001339970) · from December 31, 2013 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal